Enhancing Adherence and Safety in Gynaecological Pharmacotherapy through DUR and MRCI Integration

Authors

  • Mr. Langote Prathamesh A. Doctor of Pharmacy, Research Scholar, Department of Pharmacology, Student of ASPM’s KT Patil College of Pharmacy, Siddharth Nagar, Barshi Road, Dharashiv-413501, Maharashtra, India
  • Ms. Mada Shrija B. Doctor of Pharmacy, Research Scholar, Department of Pharmacology, Student of ASPM’s KT Patil College of Pharmacy, Siddharth Nagar, Barshi Road, Dharashiv-413 501, Maharashtra, India
  • Ms. Maralikar Mukta N. Doctor of Pharmacy, Research Scholar, Department of Pharmacology, Student of ASPM’s KT Patil College of Pharmacy, Siddharth Nagar, Barshi Road, Dharashiv-413 501, Maharashtra, India
  • Dr.Gunjegaonkar Shivshankar M. M. Pharm, Ph.D., Associate Professor, Department of Pharmacology, Faculty of ASPM’s KT Patil College of Pharmacy, Siddharth Nagar, Barshi Road, Dharashiv-413 501, Maharashtra, India
  • Mr. Shinde Mahesh U. M. Pharm, Assistant Professor, Department of Pharmacology, Faculty of ASPM’s KT Patil College of Pharmacy, Siddharth Nagar, Barshi Road, Dharashiv-413 501, Maharashtra, India
  • Dr.Joshi Amol A. M. Pharm, Ph.D., Professor and Head of the Institute, ASPM’s KT Patil College of Pharmacy, Siddharth Nagar, Barshi Road, Dharashiv-413 501, Maharashtra, India

Keywords:

Drug Utilization Review (DUR), Medication Regimen Complexity Index (MRCI), Gynecological Pharmacotherapy, Polypharmacy, Patient Adherence, Rational Drug Use, Treatment Optimization, Women's Health

Abstract

Gynecological conditions like PCOS, endometriosis, and cancers often require complex medication regimens, increasing the risk of non-adherence and adverse drug reactions. This study highlights the role of Drug Utilization Review (DUR) and the Medication Regimen Complexity Index (MRCI) in optimizing gynecological pharmacotherapy. DUR ensures appropriate and safe drug use, while MRCI evaluates regimen complexity to identify barriers to adherence. Despite their clinical value, these tools are underused due to time and system limitations. Integrating DUR and MRCI into routine care can simplify treatment, reduce polypharmacy, and enhance patient outcomes, contributing to more rational and patient-centered gynecological care.

Published

2025-06-09

How to Cite

Mr. Langote Prathamesh A., Ms. Mada Shrija B., Ms. Maralikar Mukta N., Dr.Gunjegaonkar Shivshankar M., Mr. Shinde Mahesh U., & Dr.Joshi Amol A. (2025). Enhancing Adherence and Safety in Gynaecological Pharmacotherapy through DUR and MRCI Integration. Scientific Results, (10). Retrieved from https://ojs.publisher.agency/index.php/SR/article/view/6430

Issue

No. 10 (2025): Scientific Results

Section

Medical Sciences

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.